Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Ro vs Vytora Health

Ro
Graded #38

Higher grade

vs+7.900000000000006
Vytora Health
Graded #79

Lower grade

The verdict

Ro takes it — 80.2/100 to 72.3/100.

Ro grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A heavyweight platform with brand-name access — but opaque compounded pricing drags its score.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRo +9
68
59
Dose & formulationRo +1
86
85
Clinical oversightVytora Health +10
86
96
Labs & monitoringRo +27
82
55
FulfillmentVytora Health +12
84
96
Contract termsRo +60
80
20
Ro · left barVytora Health · right bar

The numbers

MetricRoVytora Health
WeighScore80.2/10072.3/100
GradeB−C
Scorecard rank#38#79
SemaglutideNot disclosed$180/mo (all doses, compounded)
TirzepatideNot disclosed$249/mo (all doses, compounded)
CoverageMulti-stateAll 50 states
Brand-name accessYesYes
Oral / sublingualYesInjection only
Ro

Graded #38 · B−

Strengths

  • Brand-name access + insurance support
  • Oral options
  • Well-funded platform

Where it loses points

  • Does not disclose compounded pricing up front
  • Premium positioning
Vytora Health

Graded #79 · C

Strengths

  • All 50 states plus DC, with per-state video-vs-audio compliance disclosed
  • Both compounded and brand-name options on one platform — uncommon
  • LegitScript Approved and HIPAA compliant
  • Pharmacy partners named publicly: Vials Pharmacy (TX) and Greenwich Biosciences
  • Operating entity disclosed: Wasef Health, PC (Pinellas Park, FL)

Where it loses points

  • Brand-name Mounjaro/Zepbound at $1,399/mo is near retail — insured patients may do better via LillyDirect Self Pay ($449-$699/mo)
  • Compounded tirzepatide at $249/mo is mid-market, above the $149-199 floor
  • Dose tiers aren't broken out — 'all doses included' means low-dose patients pay the same as high-dose
  • Initial consultation cost not shown on the public pricing page
  • Limited per-prescriber state licensure detail

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard